TP53 and ovarian carcinoma: Likewise, an previous meta-analysis conducted by Francisco et al. [41] detected no association between the TP53 Arg72Pro polymorphism and ovarian cancer risk under any genetic model, and stratified analyses also failed to validate a genetic association.